Bink Diewertje I, Lozano-Vidal Noelia, Boon Reinier A
Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VU University, 1081HV Amsterdam, The Netherlands.
Institute of Cardiovascular Regeneration, Goethe University, 60596 Frankfurt am Main, Germany.
Noncoding RNA. 2019 Mar 19;5(1):26. doi: 10.3390/ncrna5010026.
Cardiovascular diseases are the most prominent cause of death in Western society, especially in the elderly. With the increasing life expectancy, the number of patients with cardiovascular diseases will rise in the near future, leading to an increased healthcare burden. There is a need for new therapies to treat this growing number of patients. The discovery of long non-coding RNAs has led to a novel group of molecules that could be considered for their potential as therapeutic targets. This review presents an overview of long non-coding RNAs that are regulated in vascular disease and aging and which might therefore give insight into new pathways that could be targeted to diagnose, prevent, and/or treat vascular diseases.
心血管疾病是西方社会最主要的死亡原因,尤其是在老年人中。随着预期寿命的增加,心血管疾病患者数量在不久的将来将会上升,导致医疗负担加重。需要新的疗法来治疗日益增多的此类患者。长链非编码RNA的发现导致了一类新的分子,鉴于其作为治疗靶点的潜力而值得考虑。本综述概述了在血管疾病和衰老过程中受到调控的长链非编码RNA,因此可能有助于深入了解可作为诊断、预防和/或治疗血管疾病靶点的新途径。